586-76-5
586-76-5
Chemical Structure
4-Bromobenzoic acid
- CAS 番号: 586-76-5
- Formula:C7H5BrO2
- Molecular Weight:201.02
IUPAC Name: 4-bromobenzoic acid
InChIKey: TUXYZHVUPGXXQG-UHFFFAOYSA-N
SMILES: BrC1=CC=C(C(O)=O)C=C1
Biological Activity: 4-Bromobenzoic acid is a Dehalogenase substrate and intermediate. 4-Bromobenzoic acid undergoes hydrolytic dehalogenation catalyzed by the dehalogenase of Cupriavidus sp. strain SK-3 to produce 4-Hydroxybenzoic acid (HY-Y0264). 4-Bromobenzoic acid can be utilized as the sole carbon and energy source. 4-Bromobenzoic acid can be used for the synthesis of α-amylase inhibitors[1][2].
| 製品番号 | 製品名 | 純度 | 製品説明 | Pricing | |||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
|
4-Bromobenzoic acid | 99.68% | 4-Bromobenzoic acid is a Dehalogenase substrate and intermediate. 4-Bromobenzoic acid undergoes hydrolytic dehalogenation catalyzed by the dehalogenase of Cupriavidus sp. strain SK-3 to produce 4-Hydroxybenzoic acid (HY-Y0264). 4-Bromobenzoic acid can be utilized as the sole carbon and energy source. 4-Bromobenzoic acid can be used for the synthesis of α-amylase inhibitors. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
4-Bromobenzoic acid-d4 | 98.09% | 4-Bromobenzoic acid-d4 (Benzoic-2,3,5,6-d4 acid, 4-bromo- (9CI) is the d4-labeled 4-Bromobenzoic acid (HY-78700). 4-Bromobenzoic acid is a Dehalogenase substrate and intermediate. 4-Bromobenzoic acid undergoes hydrolytic dehalogenation catalyzed by the dehalogenase of Cupriavidus sp. strain SK-3 to produce 4-Hydroxybenzoic acid (HY-Y0264). 4-Bromobenzoic acid can be utilized as the sole carbon and energy source. 4-Bromobenzoic acid can be used for the synthesis of α-amylase inhibitors. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
4-(Bromomethyl)benzoic acid | 99.46% | 4-(Bromomethyl)benzoic acid (4-Carboxybenzyl bromide) is an antiparasitic agent with low activity against Leishmania amazonensis and Trypanosoma cruzi. 4-(Bromomethyl)benzoic acid has certain cytotoxicity to PBMCs, with an IC50 of 88.8 μM. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
4-Chlorobenzoic acid (Standard) | 99.07% | 4-Chlorobenzoic acid (Standard) is the analytical standard of 4-Chlorobenzoic acid (HY-41465). This product is intended for research and analytical applications. 4-Chlorobenzoic acid is a halogenated aromatic compound that can be used as an industrial chemical and an intermediate in drug synthesis. 4-Chlorobenzoic acid is a persistent organic micropollutant and can be biodegraded through a direct dehalogenation pathway. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
p-Toluic acid (Standard) | ≥98% | p-Toluic acid (Standard) is the analytical standard of p-Toluic acid. This product is intended for research and analytical applications. p-Toluic acid (4-Methylbenzoic acid), coumarin, is a substituted benzoic acid. p-Toluic acidis synthetic p-aminomethylbenzoic acid (PAMBA), intermediates such as p-toluonitrile. p-Toluic acidMay have potential reproductive toxicity, press 1g/kgRepeated administration of doses can produce a variety of adverse effects on the epididymis. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
4-Aminobenzoic acid (Standard) | 99.96% | 4-Aminobenzoic acid (Standard) is the analytical standard of 4-Aminobenzoic acid. This product is intended for research and analytical applications. 4-Aminobenzoic acid is an intermediate in the synthesis of folic acid by bacteria, plants and fungi. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
4-Iodobenzoic acid | 99.82% | 4-Iodobenzoic acid is a 4-iodobenzoic acid that crystallizes as a dimer in the monoclinic space group P21/n, with a phase transition center temperature of 230.77 K, and exhibits intermolecular iodine-iodine van der Waals interactions. 4-Iodobenzoic acid can be used in studies of hydrogen bonding, crystal packing and solid-state phase transitions. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
4-Fluorobenzoic acid | 98.78% | 4-Fluorobenzoic acid is a drug intermediate that can be used to synthesize a series of hydrazone derivatives with antituberculosis activity and Schiff bases with DPPH radical scavenging activity. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
3-Bromobenzoic acid | 99.93% | 3-Bromobenzoic acid is an important intermediate that can be used in the synthesis of other active compounds. 3-Bromobenzoic acid can react with a variety of electrophiles to generate a variety of 2-substituted-3-bromobenzoic acid derivatives. 3-Bromobenzoic acid is also an effective corrosion inhibitor for aluminum in alkalized Persian Gulf seawater and NaOH solution. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
4-Hydroxybenzoic acid | 99.98% | 4-Hydroxybenzoic acid, a phenolic derivative of benzoic acid, could inhibit most gram-positive and some gram-negative bacteria, with an IC50 of 160 μg/mL. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
4-Hydroxybenzoic acid-13C6 | 99.9% | 4-Hydroxybenzoic acid-13C6 is the 13C labeled isotope of 4-Hydroxybenzoic acid-13C6.4-Hydroxybenzoic acid is a phenolic derivative of benzoic acid, which can inhibit most Gram-positive bacteria and some Gram-negative bacteria with an IC50 value of 160 μg/mL. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
|
|
4-Hydroxybenzoic acid-13C | 99.2% | 4-Hydroxybenzoic acid-13C is the 13C labeled 4-Hydroxybenzoic acid. 4-Hydroxybenzoic acid, a phenolic derivative of benzoic acid, could inhibit most gram-positive and some gram-negative bacteria, with an IC50 of 160 μg/mL. | ||||||||||||||||||||
|
loading...
/
|
|||||||||||||||||||||||
References
- [1]. Khan M, et al. 4-Bromobenzohydrzide derivatives as potent α-amylase enzyme inhibitors; synthesis, in vitro and in silico studies.
- [2]. Adebusoye SA, et al. Biological degradation of 4-chlorobenzoic acid by a PCB-metabolizing bacterium through a pathway not involving (chloro)catechol. Biodegradation. 2017 Feb;28(1):37-51. [Content Brief]
